Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Antiâc-Met Antibody, in Patients with Advanced Solid Tumors
Strickler, John H., LoRusso, Patricia, Salgia, Ravi, Kang, Yoon-Koo, Yen, Chia Jui, Lin, Chia-Chi, Ansell, Peter, Motwani, Monica, Wong, Shekman, Yue, Huibin, Wang, Lan, Reilly, Edward, Afar, Daniel,Volume:
19
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-19-0529
Date:
May, 2020
File:
PDF, 2.19 MB
2020